Pharmaceutical giant Pfizer is developing a vaccine specifically for pregnant women that will immunize an unborn baby while still in the womb.
Pfizer claims that infants will be protected against the respiratory syncytial virus (RSV) after birth.
RSV effects 97% of children by age 2. It has a 99.9976% survival rate. There is no need for a vaccine for it.
Yet Pfizer has decided that RSV can serve as a revenue stream, & they've created a maternal “vaccine” for it.
They will submit it to the FDA for approval by EOY.
— Jordan Schachtel @ dossier.substack.com (@JordanSchachtel) November 2, 2022
Pfizer announced Tuesday that its maternal RSV vaccine, given during pregnancy, protected infants from developing severe symptoms during the first six months after birth — a critical window of vulnerability. https://t.co/cwrQcnyHvs
— The Washington Post (@washingtonpost) November 1,…
